News

- 21/04/2020
Galenika Donates EUR 400,000 for the National Fight Against COVID 19
Belgrade, April 21, 2020 – Galenika a.d. Belgrade produced and placed 372,000 tablets of the drug Hydroxychloroquine Sulfate on the disposal of the Government of the Republic of Serbia. The value of the manufactured medicines, which Galenika will donate to the health system of the Republic of Serbia, is 400.000 euros. Hydroxychloroquine production is completed
Read more
- 16/01/2020
Galenika a.d. appoints Ricardo Vian Marques as the new general manager
Belgrade, January 16, 2020 – Beginning of the year marks a major change at the top of Galenika, the pharmaceutical company which after the privatization in 2017 became a part of the NC Group, one of the largest pharmaceutical companies in Latin America. The newly appointed General Manager is Ricardo Vian Marques. Mr. Marques hasRead more
- 24/12/2019
Galenika a.d. Belgrade completes 2019 with significant business success
Belgrade, December 24, 2019 – The new business strategy of the domestic pharmaceutical company Galenika a.d. Belgrade, resulted in a significant increase in market share in domestic and foreign markets, expansion of the portfolio and increased production in 2019. Galenika achieved a significant shift from fourth to second place in terms of market share inRead more

Galenika Donates EUR 400,000 for the National Fight Against COVID 19